| COVID-19 outcomes in patients with hematologic disease F Malard, A Genthon, E Brissot, Z van de Wyngaert, Z Marjanovic, S Ikhlef, ... Bone marrow transplantation 55 (11), 2180-2184, 2020 | 193 | 2020 |
| Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies F Malard, B Gaugler, J Gozlan, L Bouquet, D Fofana, L Siblany, D Eshagh, ... Blood cancer journal 11 (8), 142, 2021 | 124 | 2021 |
| Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort E Chiche, R Rahmé, S Bertoli, PY Dumas, JB Micol, Y Hicheri, F Pasquier, ... Blood Advances 5 (1), 176-184, 2021 | 76 | 2021 |
| Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib A Genthon, FE Nicolini, F Huguet, C Colin-Gil, M Berger, S Saugues, ... Oncotarget 11 (26), 2560, 2020 | 17 | 2020 |
| Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy A Genthon, T Chiarabini, P Baylac, N Valin, T Urbina, J Pacanowski, ... Leukemia & lymphoma 62 (6), 1502-1505, 2021 | 15 | 2021 |
| Therapy-related myeloid neoplasms following PARP inhibitors: real-life experience V Marmouset, J Decroocq, S Garciaz, G Etienne, A Belhabri, S Bertoli, ... Clinical Cancer Research 28 (23), 5211-5220, 2022 | 10 | 2022 |
| CPX-351 induces deep response and suppress the impact of poor prognosis mutations (TP53, ASXL1, RUNX1 and EVI1) defined by ELN-2017 in t-AML and MRC AML: a report from a … E Chiche, S Bertoli, R Rahmé, JB Micol, F Pasquier, P Peterlin, ... Blood 134, 1355, 2019 | 9 | 2019 |
| Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy‐induced thrombocytopenia: a French survey E Chalayer, D Cavalieri, JA Martignoles, A Genthon, E Tavernier, B Tardy Transfusion 57 (7), 1717-1723, 2017 | 9 | 2017 |
| Gemtuzumab ozogamicin combined with intensive chemotherapy in patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation A Genthon, E Brissot, F Malard, Z van de Wyngaert, A Bonnin, A Banet, ... Clinical Lymphoma Myeloma and Leukemia 20 (12), 791-796, 2020 | 5 | 2020 |
| Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients. E Chalayer, B Tardy‐Poncet, A Montmartin, K Boussoualim, A Genthon, ... British Journal of Haematology 186 (2), 2019 | 5 | 2019 |
| Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? T Alsuliman, S Faict, F Malard, A Genthon, E Brissot, Z Van de Wyngaert, ... Current research in translational medicine 69 (1), 103273, 2021 | 4 | 2021 |
| Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell … A Banet, A Bazarbachi, M Labopin, N Stocker, R Duléry, F Malard, ... Bone Marrow Transplantation 58 (1), 61-67, 2023 | 3 | 2023 |
| Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia E Sourdeau, L Suner, M Memoli, A Genthon, F Feger, L Soret, N Abermil, ... Haematologica 108 (1), 61, 2023 | 3 | 2023 |
| Les myélofibroses A Genthon, M Killian, P Mertz, P Cathebras, SG De Mestral, D Guyotat, ... La Revue de Médecine Interne 42 (2), 101-109, 2021 | 3 | 2021 |
| Poly (ADP‐ribose) polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres. PM Morice, A Genthon, T Boyer, K Bihan, J Mahé, A Sourisseau, ... British Journal of Haematology 196 (3), 2022 | 2 | 2022 |
| Interference of hyperleukocytosis in red blood cell count R Favre, A Genthon Blood, The Journal of the American Society of Hematology 131 (6), 708-708, 2018 | 2 | 2018 |
| Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC G Rey, E Daguenet, P Bonjean, R Devillier, N Fegueux, E Forcade, ... Bone Marrow Transplantation 58 (12), 1331-1338, 2023 | 1 | 2023 |
| Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study M Belhadj, B Burroni, O Kosmider, L Willems, M Temple, S Bertoli, ... British Journal of Haematology 202 (6), e50-e53, 2023 | 1 | 2023 |
| Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia. A Genthon, D Dragoi, M Memoli, P Hirsch, F Favale, L Suner, M Chaquin, ... British Journal of Haematology 198 (4), 2022 | 1 | 2022 |
| Invasive Fungal Rhinosinusitis Due to Co-infection with Mucormycosis and Exserohilum rostratum in a Patient with Acute Lymphoblastic Leukemia V Radici, E Brissot, S Chartier, J Guitard, B Fabiani, M Memoli, A Banet, ... Clinical Hematology International 4 (1), 60-64, 2022 | 1 | 2022 |
